AVBP·04272N102·US·equity·Healthcare - Biotechnology-13D/G
AVBP (ArriVent BioPharma, Inc.) is held by 74 institutional investors as of Q4 2025. Largest holders: HHLR ADVISORS, LTD. ($79.1M), FMR LLC ($74.5M), BlackRock, Inc. ($47.7M). Net institutional sentiment: Mixed.
See how AVBP's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer